Managing Menstruation in Dengue: Role of Primolut N and Provera

Overview

In cases of Dengue fever, particularly in moderate to severe dengue, managing menstruation can be clinically significant due to the risk of thrombocytopenia-associated bleeding. Suppressing menstruation may reduce bleeding complications, improve patient comfort, and allow better monitoring of hemoconcentration from hematocrit trends.

Two commonly used oral synthetic progestins for this purpose are:

Primolut N (Norethisterone 5 mg)
Provera (Medroxyprogesterone acetate 5 mg)

Mechanism of Action

Both medications are synthetic forms of progesterone, which:

Stabilize the endometrial lining
Suppress the hypothalamic-pituitary-ovarian (HPO) axis when taken in sufficient doses
Delay or prevent menstruation by mimicking luteal-phase hormonal activity

Indication in Dengue

Temporary suppression of menstruation in menstruating women during acute dengue illness, especially when platelet count <100,000/mm³
To reduce risk of menorrhagia, metrorrhagia, or dangerous uterine bleeding

⚠️ This is not a routine treatment for dengue but may be considered in patients with significant thrombocytopenia who are menstruating or at risk of bleeding.

Dosage and Administration

Primolut N (Norethisterone)

5 mg po twice daily (1×2 po pc) for 10 days
Start before the expected onset of menstruation if possible

Provera (Medroxyprogesterone acetate)

5 mg po twice daily (1×2 po pc) for 10 days
Alternative to Primolut; may be preferred if contraindications to norethisterone exist

Patient Instructions

Take after meals (po pc) to reduce nausea
Take at the same time every day to maintain stable hormone levels
Do not use as a contraceptive—this is not their role in dengue
Menstruation typically returns within 2–4 days after discontinuation

Monitoring and Follow-up

Monitor bleeding status and menstrual suppression effect
Monitor platelet count, especially if therapy is prolonged
Watch for breakthrough bleeding, especially if doses are missed
Re-evaluate if menstruation does not resume within 2 weeks after stopping

Common Side Effects

Mild: Nausea, breast tenderness, mood changes
Moderate: Bloating, weight changes, breakthrough bleeding
Severe (rare): Visual changes, severe headaches, chest pain—discontinue and seek medical attention

Contraindications

History of thromboembolic disorders
Liver disease
Breast cancer or estrogen-sensitive tumors
Undiagnosed vaginal bleeding

Use with caution and under medical supervision, especially in hospitalized dengue cases.

Clinical Pearls

In dengue with platelet count <50,000/mm³, avoid any unnecessary bleeding triggers including menstruation.
If patient already menstruating, tampon use should be avoided due to infection risk.
Hospital dengue protocols may include hormonal therapy for patients at high bleeding risk, especially with heavy menstruation.

Conclusion

Primolut and Provera are valuable tools for safely suppressing menstruation during dengue infection when clinically indicated. Their role is not in treating dengue itself, but in supportive management to minimize bleeding risks. As with all hormonal therapies, use requires careful patient selection, education, and follow-up.